UCB (PK) Stock Quote UCBJY - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

95.56

Bid

95.19

Ask

95.69

Volume

5,865

95.46 Day's Range 95.94

45.55 52 Week Range 100.66

Market Cap

36.235B

Previous Close

96.02

Open

95.94

Last Trade

95.19

Last Trade Time

13:37:32

Financial Volume

$ 560,887

VWAP

95.6328

Average Volume (3m)

12,855

Shares Outstanding

379,189,796

Dividend Yield

0.96%

PE Ratio

202.41

Earnings Per Share (EPS)

0.9

Revenue

4.87B

Net Profit

343M

UCB, Brussels, Belgium is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. UCB, Brussels, Belgium is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.

Sector

Pharmaceutical Preparations

Industry

Chemicals & Allied Products

Website

www.ucb.com

Headquarters

Brussels, Brussels-capital Region, Bel

Founded

1928

UCB (PK) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker UCBJY. The last closing price for UCB (PK) was $96.02. Over the last year, UCB (PK) shares have traded in a share price range of $ 45.55 to $ 100.66.

UCB (PK) currently has 379,189,796 shares outstanding. The market capitalization of UCB (PK) is $36.41 billion. UCB (PK) has a price to earnings ratio (PE ratio) of 202.41.

UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services

UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services Judges highlight value-added partnership and finance transformation as leading examples of innovation in...

New Data Identify Important Factors that May Reduce Hospitalizations among People with Epilepsy in the U.S.

New Data Identify Important Factors that May Reduce Hospitalizations among People with Epilepsy in the U.S. Results of retrospective analysis show use of newer anti-epilepsy drugs, access to...

UCB Announces Crohn's Disease Data to be Presented at Digestive Disease Week 2015

UCB Announces Crohn's Disease Data to be Presented at Digestive Disease Week 2015 PR Newswire ATLANTA, May 16, 2015 ATLANTA, May 16, 2015 /PRNewswire/ -- UCB, a global biopharmaceutical company...

UCB announces US and EU regulatory filings for the investigational antiepileptic drug brivaracetam

UCB announces US and EU regulatory filings for the investigational antiepileptic drug brivaracetam - Major milestone for brivaracetam is latest step towards UCB goal of extending treatment...

UCB and Emory Present New Assessment of Epilepsy Prevalence and Incidence in the U.S. at 2014 American Epilepsy Society Annua...

UCB and Emory Present New Assessment of Epilepsy Prevalence and Incidence in the U.S. at 2014 American Epilepsy Society Annual Meeting PR Newswire ATLANTA, Dec. 8, 2014 ATLANTA, Dec. 8, 2014...

UCB announces first presentation of primary data from latest Phase 3 study evaluating brivaracetam as adjunctive treatment of...

UCB announces first presentation of primary data from latest Phase 3 study evaluating brivaracetam as adjunctive treatment of partial-onset seizures in epilepsy -- Primary efficacy and safety...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-2.88	-2.92563998375	98.44	98.93	93.22	8775	96.19302866	DR
4	-4.29	-4.296444667	99.85	100.66	93.22	8523	98.01311099	DR
12	-0.47	-0.489430386338	96.03	100.66	86.71	12855	96.69287049	DR
26	16.94	21.546680234	78.62	100.66	78.18	16201	91.65258649	DR
52	50.01	109.79143798	45.55	100.66	45.55	17312	77.46951115	DR
156	45.56	91.12	50	100.66	32.82	20718	51.55344639	DR
260	50.1	110.206775187	45.46	100.66	32.45	20010	52.72972006	DR

UCBJY - Frequently Asked Questions (FAQ)

What is the current UCB (PK) share price?

The current share price of UCB (PK) is $ 95.56

How many UCB (PK) shares are in issue?

UCB (PK) has 379,189,796 shares in issue

What is the market cap of UCB (PK)?

The market capitalisation of UCB (PK) is USD 36.41B

What is the 1 year trading range for UCB (PK) share price?

UCB (PK) has traded in the range of $ 45.55 to $ 100.66 during the past year

What is the PE ratio of UCB (PK)?

The price to earnings ratio of UCB (PK) is 202.41

What is the cash to sales ratio of UCB (PK)?

The cash to sales ratio of UCB (PK) is 14.27

What is the reporting currency for UCB (PK)?

UCB (PK) reports financial results in EUR

What is the latest annual turnover for UCB (PK)?

The latest annual turnover of UCB (PK) is EUR 4.87B

What is the latest annual profit for UCB (PK)?

The latest annual profit of UCB (PK) is EUR 343M

What is the registered address of UCB (PK)?

The registered address for UCB (PK) is 60, ALLEE DE LA RECHERCHE, BRUSSELS, BRUSSELS-CAPITAL REGION, B-1070

What is the UCB (PK) website address?

The website address for UCB (PK) is www.ucb.com

Which industry sector does UCB (PK) operate in?

UCB (PK) operates in the CHEMICALS & ALLIED PRODUCTS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
RTNBroot9B Holdings Inc (CE)	$ 0.003003 (300,200.00%)	333
CTRYFCountry Garden Holdings Company Limited (CE)	$ 0.075 (37,400.00%)	1.69k
CNQQFClean TeQ Water Ltd (PK)	$ 0.18 (25,614.29%)	425
QBIOQ BioMed Inc (CE)	$ 0.0002 (19,900.00%)	487
MGTIMGT Capital Investments Inc (CE)	$ 0.0002 (19,900.00%)	11.73k
JFTHJapan Food Tech Holdings Inc (CE)	$ 0.000001 (-99.99%)	150
CONNQConns Inc (CE)	$ 0.000001 (-99.98%)	250
SPECSpectaire Holdings Inc (CE)	$ 0.000001 (-99.90%)	1,000
EGOCEnergy One Corporation (CE)	$ 0.000001 (-99.90%)	21.8k
GRTSQGritstone bio Inc (CE)	$ 0.000001 (-99.90%)	223.35k
PDGOParadigm Oil and Gas Inc (PK)	$ 0.0001 (-50.00%)	438.84M
RDARRaadr Inc (PK)	$ 0.00105 (-4.55%)	234.04M
HMBLHUMBL Inc (PK)	$ 0.0008 (-11.11%)	208.11M
COSGCosmos Group Holdings Inc (PK)	$ 0.00005 (4,900.00%)	180.3M
GRLFGreen Leaf Innovations Inc (PK)	$ 0.000001 (-99.33%)	76.21M